For manufacture of Recombinant Streptokinase, under Technology Licensed from CSIR-IMTECH.STREPTOKINASE is a bacterial protein, produced by several species of streptococci, that dissolves the human blood clots. It is a potent activator of plasminogen, the inactive precursor of plasmin. The introduction of streptokinase into medical practice, marked significant decline in death rates from acute heart attack. […]
BIOT 405: More affordable version of therapeutic protein recombinant Streptokinase to address over a million ST elevated Micardial Infraction (STEMI) deaths in part of the world where affordability is the key. Cardiovascular diseases (CVD) have been leading cause of morbidity and mortality in Indian subcontinent and Myocardial Infraction is one of the major reason for […]
The oil game is still played very traditionally in the Middle East, but companies such as Dubai’s biotech firm Epygen Labs are slowly encouraging the sector to rethink the old ways. Debayan Ghosh (below) and Ariyarathenam Manickam, a researcher and a businessman respectively, were the first to move into Dubai’s DuBiotech Park in 2005, launching […]
To Develop Recycled Fiber For Kraft Mills In Mena Regions Facing Challenges In Water Quality Due To Extreme Recirculation At one of Asia’s leading Pulp and Paper technology shows held in Jakarta during April 2015, Epygen presented it’s innovative Enzymatic concept to treat recycled fiber under highly closed white water system prevailing in Middle East […]
Epygen received overwhelming response at the the Life Sciences Career Fair held at Dubiotech Lab Complex on 26th March 2015. With a view to inspire potential candidates and students aspiring to be successful in the field of Biotechnology, Epygen encouraged students in Biotechnology, Bioprocess Engineering or Molecular Genetics for conducting research and internship projects under guidance […]
Economical oil recovery NOCS are increasingly looking to small, agile research and development firms to deliver innovative approaches to enhanced oil recovery.
According to the WHO, amongst all non-communicable diseases, cardiovascular disease (CVD) is the major cause of death in both developed and developing countries. In the year 2008, nearly 17 million people died of CVD around the globe, representing 30% death amongst all non-communicable diseases worldwide. The major chunk of death coming from the lower income […]
Epygen is pleased to announce opening of a state of art, Biotech incubation facility at Navi Mumbai, India. This consists of a full- fledged Bioprocessing Pilot facility, a Microbiology Laboratory and a Protein analysis division, suitable for evaluation and incubation of licensed Technologies to produce Therapeutic proteins and Enzymes of interest. A large scale Biotech […]
Epygen presented its technology on enzymatic kinetics at the World Congress on Industrial Biotechnology and Bioprocessing in Orlando, Florida. To use enzymatic bioconversion lots effectively, it is key to understand influences by range of parameters. This statistical model will be used infuture to develop artificial intelligence in maximizing enzymatic bioconversion. The topic was well received by […]
Epygen presented its mathematical model, for kinetic predictability of biopolymer breaking enzyme (Paper No. 292) at the American Chemical Society, national meet, San Diego, Spring 2012. For a horizontal section drilled, using, biopolymer based fluids, the barrier must be completely broken to maximize production rates. Since most enzymes tend to completely deactivate at harsh downhole […]
